Show simple item record

dc.contributor.authorConseil exécutif, 120
dc.coverage.spatialGenèveen
dc.date.accessioned2012-03-21T09:01:47Z
dc.date.available2012-03-21T09:01:47Z
dc.date.issued2007
dc.identifier.govdocEB120/7
dc.identifier.urihttps://iris.who.int/handle/10665/22765
dc.descriptionConseil exécutif, cent vingtième session, point 4.9 de l’ordre du jour provisoire, 9 p.en
dc.language.isofren
dc.publisherOrganisation mondiale de la Santéen
dc.subjectPharmaceutical productsen
dc.subject.meshPharmaceutical Preparationsen
dc.subject.meshDrug Resistance, Microbialen
dc.subject.meshDrug Utilizationen
dc.subject.meshInformation Systemsen
dc.subject.meshDrugs, Essentialen
dc.subject.meshChild Advocacyen
dc.titleProgrès en matière d’usage rationnel des médicaments, et notamment amélioration des médicaments destinés aux enfants : usage rationnel des médicaments : rapport du Secrétariaten
dc.typeGoverning body documentsen
dc.subject.meshqualifieradministration and dosageen
dc.subject.meshqualifiereconomicsen
dc.subject.meshqualifierstandardsen
who.relation.languageVersion10665/25508en
who.relation.languageVersion10665/21904en
who.relation.languageVersion10665/24716en
who.relation.languageVersion10665/24157en
who.relation.languageVersion10665/23228en
who.relation.languageVersion10665/69523en


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

  • EB120
    22-30 January 2007

Show simple item record